AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GOSERELIN
6 registrations across 3 African markets— 6 active
Markets with GOSERELIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZOLADEX LA IMPLANT; SUBCUTANEOUS | 🇿🇼Zimbabwe | ASTRA ZENECA LIMITED | active | Apr 2030 |
| ZOLADEX INJECTABLE; INJECTION | 🇿🇼Zimbabwe | ASTRA ZENECA LIMITED | active | Dec 2027 |
| Zoladex Injection | 🇹🇿Tanzania | AstraZeneca UK Limited | active | — |
| Zoladex LA 10.8 mg Sub-dermal Implant | 🇹🇿Tanzania | AstraZeneca UK Limited | active | — |
| GOSERELIN PARENTERAL
ORDINARY PRE-
FILLED SYRINGES | 🇺🇬Uganda | ASTRA ZENECA | active | — |
| GOSERELIN PARENTERAL
ORDINARY PRE-
FILLED SYRINGES | 🇺🇬Uganda | ASTRA ZENECA | active | — |
GOSERELIN in Africa — Regulatory Overview
GOSERELIN is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Uganda, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.